Each topic below is written at two levels, one for clinicians and one for patients, from a single sourced research base. Previews are shown here. I send the full clinician and patient versions on request, so you get the version that fits your audience.
Demonstrates handling a hyped topic responsibly: it makes the genuine case for continuous glucose monitoring as a behavior tool while being candid that glucose swings in healthy people are normal.
Stick a continuous glucose monitor on your arm for two weeks and one thing becomes obvious fast: your blood sugar is busy. It climbs after lunch, dips before dinner, does something strange after that late-night bowl of cereal, and behaves completely differently than your friend's does after the exact same meal. For a lot of people, that is the first time their own metabolism has ever talked back to them.
So what is actually worth knowing here? CGMs were built for people with diabetes, where they genuinely change lives. Using one without diabetes is a newer idea, and the science is a mix of "yes, this is real and useful" and "no, please do not read too much into it." Here is the honest version.
Full clinician and patient versions available on request.
Demonstrates defending a product category without overclaiming: it presents berberine's genuine, modest evidence favorably while honestly separating it from the "nature's Ozempic" overstatement.
If you spend any time on health TikTok, you have probably seen berberine called "nature's Ozempic." It is a great hook. It is also not accurate, and you deserve a straight answer before you spend money on a supplement. So here is the honest version from a pharmacist: berberine is one of the better-studied natural compounds for blood sugar, the effect on weight is small, and it is not a stand-in for a prescription drug.
To be specific about the gap: the weight effect people typically see with berberine is in the range of about 5 to 10 pounds, while the newer GLP-1 medications have produced average losses of roughly 30 to 50 pounds in their big clinical trials. Same goal, very different league.
Full clinician and patient versions available on request.
Demonstrates scientific honesty that protects a brand: it presents NAD+ repletion fairly while drawing a clean line at the unproven longevity claims, so the content reads as credible rather than hyped.
If you have shopped for longevity supplements lately, you have run into NAD+ boosters. The two big names are NMN and NR. The marketing around them can get breathless, so here is the calm version from someone who reads the trials. These supplements do one thing the science clearly backs: they raise a molecule in your body called NAD+ that drops as you age.
Whether that translates into actually aging slower or living longer is still an open question. Both things can be true at once, and a good brand will tell you both.
Full clinician and patient versions available on request.
A full clinical reference on what compounded and brand-name GLP-1 medications share, how they differ, and what quality compounding looks like, written in both a clinician and a patient version. This one I share privately rather than post, so it stays useful to the clients I write it for.
Request this sample privatelyWant a sample in a different therapeutic area, such as neurology, immunology, or oncology? Just ask.